A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma

by Papayannidis, C, DeAngelo, D J, Stock, W, Huang, B, Shaik, M N, Cesari, R, Zheng, X, Reynolds, J M, English, P A, Ozeck, M, Aster, J C, Kuo, F, Huang, D, Lira, P D, McLachlan, K R, Kern, K A, Garcia-Manero, G, Martinelli, G
Published 2015